Multiple sclerosis: A risk factor analysis in Iran

Archives of Iranian Medicine

Volumn 5, Issue 3, 2002, Pages 191-193

  Pour, Gholam Ali Yousefi ^a   Rasekhi, Ali Reza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Incidence; Iran; Multiple sclerosis; Prevalence

Indexed keywords

ADULT; ARTICLE; CHILDBIRTH; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMYELINATING DISEASE; DEPRESSION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INTERVIEW; IRAN; IRAQ; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; QUESTIONNAIRE; RADIOLOGIST; RASH; RISK ASSESSMENT; VIRUS INFECTION; WAR;

EID: 0036662117     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Weinshenker BG. Natural history of multiple sclerosis. Ann Neurol. 1994; 36: 6-11.
2. Weinshenker BG. Natural history of multiple sclerosis: update 1998. Semin Neurol. 1998; 18: 301-7.
3. Forbes RB, Swingler RJ. Estimating the prevalence of multiple sclerosis in United Kingdom by using capture-recapture methodology. Am J Epidemiol. 1999; 149: 1016-24.
4. Kurtzke JF, Delasnerie-Laupretre N, Wallin MT. Multiple sclerosis in North African migrants to France. Acta Neurol Scand. 1998; 98: 302-9.
5. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin. 1996; 14: 291-308.
6. Poser CM. The epidemiology of multiple sclerosis, a general overview. Ann Neurol. 1994; 36 (Suppl 2): 180-93.
7. Yousefipour GA. Multiple sclerosis in the Province of Fars. The sixth international Congress of Geographic Medicine. May 3-6, 1993. Presented as an oral lecture.
8. Amirzargar A, Mytilineos J, Yousefipour GA, et al. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis patients. Eur Immunogenet. 1998; 25: 297-301.
9. Hogancamp WE, Rodriguez M, Weinshenker BG. The epidemiology of multiple sclerosis. Mayo Clin Proc. 1997; 72: 871-8.
10. Fernandez O. Genetic and environmental factors in MS. Rev Neurol. 2000; 30: 964-7.
11. Hernan MA, Hohol MJ, Olek MJ, et al. Oral contraceptive and the incidence of multiple sclerosis. Neurology. 2000; 55: 848-54.
12. Hammond SR, McLeod JG. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain. 2000; 123: 968-74.
13. Kurtzke JF. Multiple sclerosis in time and space-geographic clues to cause. J Neurovirol. 2000; 2: 134-40.
14. Ale-Yasin H, Sarai A, Alaeddini F, et al. Multiple sclerosis: a study of 318 cases. Arch Iranian Med. 2002; 5: 24-27.
15. Shirzadi M, Zare M, Moghaddasi M. Multiple sclerosis in Isfahan, Iran. Irn J Med Sci. 1992; 17: 59-61.